New service offers rapid, consultant-led prostate scans to support early detection and a proactive approach to men’s health ...

A UK-led international study has identified steps that can be taken to improve the quality of MRI scans for prostate cancer screening. Research, published in Radiology, found "relatively simple and ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

A new international study from UCL and UCLH that aims to improve the quality of MRI scans for prostate cancer screening has identified simple ways to treble the number of scans that are of optimal ...

A nationwide survey of prostate MRI practices in the UK revealed the universal adoption of pre-biopsy MRI across all NHS trusts, with 73.1% using multiparametric MRI protocols. However, significant ...

A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...

We’re prostate cancer experts. Here are the benefits of quick and targeted MRI scans - Urologists, radiologists and ...

Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research. The REIMAGINE study, published today in ...

Millions of men could benefit from a faster 15-minute prostate cancer scan that paves the way to a national screening programme. The new MRI scan takes half the time of the current one and costs half ...

Bulletin: ...FROST ADVISORY REMAINS IN EFFECT FROM 2 AM TO 9 AM EDT SATURDAY... * WHAT...Temperatures as low as 32 degrees will result in frost formation. * WHERE ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.